• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病脑中淀粉样β蛋白异构体的多样性。

Diversity of Amyloid-beta Proteoforms in the Alzheimer's Disease Brain.

机构信息

Department of Neurology, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO, 63110, United States.

Proteomics Center of Excellence, Northwestern University, Evanston, IL, United States.

出版信息

Sci Rep. 2017 Aug 25;7(1):9520. doi: 10.1038/s41598-017-10422-x.

DOI:10.1038/s41598-017-10422-x
PMID:28842697
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5572664/
Abstract

Amyloid-beta (Aβ) plays a key role in the pathogenesis of Alzheimer's disease (AD), but little is known about the proteoforms present in AD brain. We used high-resolution mass spectrometry to analyze intact Aβ from soluble aggregates and insoluble material in brains of six cases with severe dementia and pathologically confirmed AD. The soluble aggregates are especially relevant because they are believed to be the most toxic form of Aβ. We found a diversity of Aβ peptides, with 26 unique proteoforms including various N- and C-terminal truncations. N- and C-terminal truncations comprised 73% and 30%, respectively, of the total Aβ proteoforms detected. The Aβ proteoforms segregated between the soluble and more insoluble aggregates with N-terminal truncations predominating in the insoluble material and C- terminal truncations segregating into the soluble aggregates. In contrast, canonical Aβ comprised the minority of the identified proteoforms (15.3%) and did not distinguish between the soluble and more insoluble aggregates. The relative abundance of many truncated Aβ proteoforms did not correlate with post-mortem interval, suggesting they are not artefacts. This heterogeneity of Aβ proteoforms deepens our understanding of AD and offers many new avenues for investigation into pathological mechanisms of the disease, with implications for therapeutic development.

摘要

淀粉样蛋白-β(Aβ)在阿尔茨海默病(AD)的发病机制中起着关键作用,但人们对 AD 脑中存在的 Aβ 蛋白形式知之甚少。我们使用高分辨率质谱法分析了来自 6 例严重痴呆和经病理证实的 AD 患者脑中可溶性聚集物和不溶性物质的完整 Aβ。可溶性聚集物尤其重要,因为它们被认为是 Aβ 毒性最强的形式。我们发现了多种 Aβ 肽,包括 26 种独特的蛋白形式,包括各种 N-和 C-末端截断。N-和 C-末端截断分别占检测到的总 Aβ 蛋白形式的 73%和 30%。Aβ 蛋白形式在可溶性和更不溶性聚集物之间分离,N-末端截断主要存在于不溶性物质中,C-末端截断则分离到可溶性聚集物中。相比之下,经典 Aβ 构成了所鉴定的蛋白形式的少数(15.3%),且不能区分可溶性和更不溶性的聚集物。许多截断的 Aβ 蛋白形式的相对丰度与死后间隔时间没有相关性,表明它们不是人为因素造成的。Aβ 蛋白形式的这种异质性加深了我们对 AD 的理解,并为研究疾病的病理机制提供了许多新途径,对治疗开发具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ee9/5572664/d5d731c5c2ef/41598_2017_10422_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ee9/5572664/95ce6e6acffe/41598_2017_10422_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ee9/5572664/d12007453f60/41598_2017_10422_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ee9/5572664/244c0042ea87/41598_2017_10422_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ee9/5572664/d5d731c5c2ef/41598_2017_10422_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ee9/5572664/95ce6e6acffe/41598_2017_10422_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ee9/5572664/d12007453f60/41598_2017_10422_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ee9/5572664/244c0042ea87/41598_2017_10422_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ee9/5572664/d5d731c5c2ef/41598_2017_10422_Fig4_HTML.jpg

相似文献

1
Diversity of Amyloid-beta Proteoforms in the Alzheimer's Disease Brain.阿尔茨海默病脑中淀粉样β蛋白异构体的多样性。
Sci Rep. 2017 Aug 25;7(1):9520. doi: 10.1038/s41598-017-10422-x.
2
Soluble Amyloid-beta Aggregates from Human Alzheimer's Disease Brains.人阿尔茨海默病脑中的可溶性淀粉样β聚集物。
Sci Rep. 2016 Dec 5;6:38187. doi: 10.1038/srep38187.
3
Non-canonical soluble amyloid-beta aggregates and plaque buffering: controversies and future directions for target discovery in Alzheimer's disease.非典型可溶性淀粉样β聚集体与斑块缓冲:阿尔茨海默病靶点发现的争议与未来方向
Alzheimers Res Ther. 2017 Aug 17;9(1):62. doi: 10.1186/s13195-017-0293-3.
4
The Dynamics of β-Amyloid Proteoforms Accumulation in the Brain of a 5xFAD Mouse Model of Alzheimer's Disease.阿尔茨海默病 5xFAD 小鼠模型脑内β-淀粉样蛋白蛋白构象聚集的动力学研究。
Int J Mol Sci. 2021 Dec 21;23(1):27. doi: 10.3390/ijms23010027.
5
Unveiling Brain Aβ Heterogeneity Through Targeted Proteomic Analysis.通过靶向蛋白质组学分析揭示大脑β-淀粉样蛋白的异质性
Methods Mol Biol. 2018;1779:23-43. doi: 10.1007/978-1-4939-7816-8_3.
6
Aβ truncated species: Implications for brain clearance mechanisms and amyloid plaque deposition.β 淀粉样肽截断种:对大脑清除机制和淀粉样斑块沉积的影响。
Biochim Biophys Acta Mol Basis Dis. 2018 Jan;1864(1):208-225. doi: 10.1016/j.bbadis.2017.07.005. Epub 2017 Jul 13.
7
Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease.人脑中淀粉样β肽聚集和积累的生化阶段及其与症状前和病理前阿尔茨海默病的关系。
Brain. 2014 Mar;137(Pt 3):887-903. doi: 10.1093/brain/awt362. Epub 2014 Feb 10.
8
Molecular Profiles of Amyloid-β Proteoforms in Typical and Rapidly Progressive Alzheimer's Disease.典型和快速进展性阿尔茨海默病中淀粉样β蛋白异构体的分子特征。
Mol Neurobiol. 2022 Jan;59(1):17-34. doi: 10.1007/s12035-021-02566-9. Epub 2021 Oct 7.
9
Disruption of amyloid plaques integrity affects the soluble oligomers content from Alzheimer disease brains.淀粉样斑块完整性的破坏会影响阿尔茨海默病大脑中的可溶性寡聚体含量。
PLoS One. 2014 Dec 8;9(12):e114041. doi: 10.1371/journal.pone.0114041. eCollection 2014.
10
How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.膜如何引发阿尔茨海默病?神经节苷脂簇上的β淀粉样蛋白形成毒性淀粉样纤维。
Acc Chem Res. 2014 Aug 19;47(8):2397-404. doi: 10.1021/ar500127z. Epub 2014 Jul 16.

引用本文的文献

1
Isomerized Aβ in the brain can distinguish the status of amyloidosis in the Alzheimer's disease spectrum.大脑中的异构化β淀粉样蛋白(Aβ)能够区分阿尔茨海默病谱系中淀粉样变性的状态。
Acta Neuropathol. 2025 Jul 22;150(1):7. doi: 10.1007/s00401-025-02914-2.
2
Discovery of Proteoforms Associated With Alzheimer's Disease Through Quantitative Top-Down Proteomics.通过定量自上而下蛋白质组学发现与阿尔茨海默病相关的蛋白质异构体
Mol Cell Proteomics. 2025 May 5;24(6):100983. doi: 10.1016/j.mcpro.2025.100983.
3
In Vivo Seeding of Amyloid-β Protein and Implications in Modeling Alzheimer's Disease Pathology.

本文引用的文献

1
An Automated Pipeline to Monitor System Performance in Liquid Chromatography-Tandem Mass Spectrometry Proteomic Experiments.一种用于监测液相色谱-串联质谱蛋白质组学实验中系统性能的自动化流程。
J Proteome Res. 2016 Dec 2;15(12):4763-4769. doi: 10.1021/acs.jproteome.6b00744. Epub 2016 Oct 4.
2
The amyloid hypothesis of Alzheimer's disease at 25 years.阿尔茨海默病淀粉样蛋白假说25年回顾
EMBO Mol Med. 2016 Jun 1;8(6):595-608. doi: 10.15252/emmm.201606210. Print 2016 Jun.
3
A Method for Label-Free, Differential Top-Down Proteomics.
淀粉样β蛋白的体内接种及其在阿尔茨海默病病理建模中的意义。
Biomolecules. 2025 Apr 11;15(4):571. doi: 10.3390/biom15040571.
4
Heterotypic Seeding Generates Mixed Amyloid Polymorphs.异型接种产生混合淀粉样多形体。
Small Sci. 2024 Sep;4(9). doi: 10.1002/smsc.202400109. Epub 2024 Jun 22.
5
Inducers and modulators of protein aggregation in Alzheimer's disease - Critical tools for understanding the foundations of aggregate structures.阿尔茨海默病中蛋白质聚集的诱导剂和调节剂——理解聚集体结构基础的关键工具。
Neurotherapeutics. 2025 Apr;22(3):e00512. doi: 10.1016/j.neurot.2024.e00512. Epub 2025 Jan 3.
6
The Features of Beta-Amyloid Phosphorylation in Alzheimer's Disease.阿尔茨海默病中β-淀粉样蛋白磷酸化的特征
Acta Naturae. 2024 Jul-Sep;16(3):93-101. doi: 10.32607/actanaturae.27456.
7
Type-1-to-type-2 transition of brain microvascular pericytes induced by cytokines and disease-associated proteins: Role in neuroinflammation and blood-brain barrier disruption.细胞因子和疾病相关蛋白诱导的脑微血管周细胞从1型向2型转变:在神经炎症和血脑屏障破坏中的作用
J Cereb Blood Flow Metab. 2025 Mar;45(3):405-420. doi: 10.1177/0271678X241296270. Epub 2024 Oct 30.
8
Native ion mobility-mass spectrometry reveals the binding mechanisms of anti-amyloid therapeutic antibodies.天然离子淌度-质谱揭示了抗淀粉样蛋白治疗抗体的结合机制。
Protein Sci. 2024 Jun;33(6):e5008. doi: 10.1002/pro.5008.
9
Heterotypic Seeding Generates Mixed Amyloid Polymorphs.异型接种产生混合淀粉样多形体。
bioRxiv. 2024 Mar 17:2024.03.15.585264. doi: 10.1101/2024.03.15.585264.
10
Cyclic Ion Mobility-Mass Spectrometry and Tandem Collision Induced Unfolding for Quantification of Elusive Protein Biomarkers.循环离子淌度-质谱联用技术和串联碰撞诱导展开技术用于定量分析难以捉摸的蛋白质生物标志物。
Anal Chem. 2024 Apr 16;96(15):6021-6029. doi: 10.1021/acs.analchem.4c00477. Epub 2024 Apr 1.
一种用于无标记、差异自上而下蛋白质组学的方法。
Methods Mol Biol. 2016;1410:121-33. doi: 10.1007/978-1-4939-3524-6_8.
4
Tau post-translational modifications in wild-type and human amyloid precursor protein transgenic mice.野生型和人淀粉样前体蛋白转基因小鼠中tau蛋白的翻译后修饰
Nat Neurosci. 2015 Aug;18(8):1183-9. doi: 10.1038/nn.4067. Epub 2015 Jul 20.
5
Age and amyloid effects on human central nervous system amyloid-beta kinetics.年龄和淀粉样蛋白对人类中枢神经系统β-淀粉样蛋白动力学的影响。
Ann Neurol. 2015 Sep;78(3):439-53. doi: 10.1002/ana.24454. Epub 2015 Jul 20.
6
Neuropathologic assessment of participants in two multi-center longitudinal observational studies: the Alzheimer Disease Neuroimaging Initiative (ADNI) and the Dominantly Inherited Alzheimer Network (DIAN).两项多中心纵向观察性研究参与者的神经病理学评估:阿尔茨海默病神经影像学倡议(ADNI)和显性遗传性阿尔茨海默病网络(DIAN)。
Neuropathology. 2015 Aug;35(4):390-400. doi: 10.1111/neup.12205. Epub 2015 May 12.
7
Quantitative proteomics reveals protein-protein interactions with fibroblast growth factor 12 as a component of the voltage-gated sodium channel 1.2 (nav1.2) macromolecular complex in Mammalian brain.定量蛋白质组学揭示了成纤维细胞生长因子12作为哺乳动物大脑中电压门控钠通道1.2(nav1.2)大分子复合物的一个组成部分参与蛋白质-蛋白质相互作用。
Mol Cell Proteomics. 2015 May;14(5):1288-300. doi: 10.1074/mcp.M114.040055. Epub 2015 Feb 27.
8
Quantitative measurement of intact alpha-synuclein proteoforms from post-mortem control and Parkinson's disease brain tissue by intact protein mass spectrometry.通过完整蛋白质质谱法对死后对照和帕金森病脑组织中完整的α-突触核蛋白蛋白亚型进行定量测量。
Sci Rep. 2014 Jul 23;4:5797. doi: 10.1038/srep05797.
9
Truncated and modified amyloid-beta species.截断和修饰的淀粉样β物质。
Alzheimers Res Ther. 2014 May 26;6(3):28. doi: 10.1186/alzrt258. eCollection 2014.
10
Applying label-free quantitation to top down proteomics.将无标记定量应用于自上而下蛋白质组学。
Anal Chem. 2014 May 20;86(10):4961-8. doi: 10.1021/ac500395k. Epub 2014 May 7.